BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17094431)

  • 1. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
    Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
    Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus.
    Mo Q; Lu S; Garippa C; Brownstein MJ; Simon NG
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):135-43. PubMed ID: 19429443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.
    Bruckheimer EM; Spurgers K; Weigel NL; Logothetis C; McDonnell TJ
    J Urol; 2003 Apr; 169(4):1553-7. PubMed ID: 12629413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
    Geier R; Adler S; Rashid G; Klein A
    Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
    Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
    Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
    Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG).
    Labrie F; Luu-The V; Martel C; Chernomoretz A; Calvo E; Morissette J; Labrie C
    J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):52-8. PubMed ID: 16797178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of dihydrotestosterone on the transcriptions and expressions of Smad3 and Smad4 in LNCaP cell line].
    Gu RG; Zhou CW; Ma QZ
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):211-4. PubMed ID: 16597033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
    Ma C; Yoshioka M; Boivin A; Gan L; Takase Y; Labrie F; St-Amand J
    Prostate; 2009 Feb; 69(3):293-316. PubMed ID: 19023869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG.
    Chen M; Chen LM; Chai KX
    Prostate; 2006 Jun; 66(9):911-20. PubMed ID: 16541421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK; Grootegoed JA; Blok LJ
    Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.